Covered recipient · General Payments record
ALLEN C HUANG
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2024
$2,303.91
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $713.05 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $528.73 | 14 |
| Teva Pharmaceuticals USA, Inc. | $120.79 | 1 |
| Ipsen Biopharmaceuticals, Inc | $43.02 | 2 |
| Otsuka America Pharmaceutical, Inc. | $20.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.36 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947464 | CMS |
| ABBVIE INC. | $20.02 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947466 | CMS |
| ABBVIE INC. | $31.86 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947468 | CMS |
| ABBVIE INC. | $124.97 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947470 | CMS |
| ABBVIE INC. | $18.97 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947472 | CMS |
| ABBVIE INC. | $10.02 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947474 | CMS |
| ABBVIE INC. | $75.00 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947476 | CMS |
| ABBVIE INC. | $8.02 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947478 | CMS |
| ABBVIE INC. | $12.31 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947480 | CMS |
| ABBVIE INC. | $29.88 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947482 | CMS |
| ABBVIE INC. | $14.02 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947484 | CMS |
| ABBVIE INC. | $24.43 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947486 | CMS |
| ABBVIE INC. | $10.22 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947488 | CMS |
| ABBVIE INC. | $24.65 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947490 | CMS |
| Ipsen Biopharmaceuticals, Inc | $15.89 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091989649 | CMS |
| Ipsen Biopharmaceuticals, Inc | $27.13 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091989651 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.51 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118910571 | CMS |
| Teva Pharmaceuticals USA, Inc. | $120.79 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151476482 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.